Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (41 quarters reported)
$735M in Q2 2013 → $2.56B now. Hover for any quarter.
As reported for the quarter ended June 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Amgen Inc. | 5.4% | Added 11% | 616,539 | $137M |
| Johnson & Johnson | 4.7% | Unchanged | 721,779 | $119M |
| Gilead Sciences, Inc. | 4.6% | Trimmed 1.7% | 1,533,884 | $118M |
| Regeneron Pharmaceuticals, Inc. | 4.5% | Added 13% | 161,418 | $116M |
| Vertex Pharmaceuticals Inc. | 4.4% | Trimmed 3.7% | 318,043 | $112M |
| Eli Lilly And Company | 3.9% | Trimmed 26% | 213,352 | $100M |
| Unitedhealth Group Inc. | 3.9% | Trimmed 12% | 206,961 | $99.5M |
| Merck & Co., Inc. | 3.3% | Added 32% | 728,154 | $84M |
| Abbvie Inc. | 2.9% | Added 6.7% | 545,629 | $73.5M |
| Biogen Inc. | 2.8% | Added 2.9% | 247,943 | $70.6M |
| Astrazeneca PLC | 2.7% | Trimmed 1.6% | 976,676 | $69.9M |
| Illumina, Inc. | 2.5% | Trimmed 3.2% | 336,979 | $63.2M |
| Abbott Laboratories | 2.4% | Trimmed 11% | 552,455 | $60.2M |
| Pfizer Inc. | 2.3% | Trimmed 8.5% | 1,624,476 | $59.6M |
| Thermo Fisher Scientific Inc. | 2.0% | Added 5.6% | 98,987 | $51.6M |
| Elevance Health, Inc. | 2.0% | Unchanged | 114,070 | $50.7M |
| Moderna, Inc. | 1.6% | Added 6.7% | 343,695 | $41.8M |
| Boston Scientific Corp. | 1.4% | Added 16% | 657,790 | $35.6M |
| Danaher Corp. | 1.3% | Added 35% | 142,813 | $34.3M |
| Medtronic PLC | 1.2% | Trimmed 0.0% | 344,417 | $30.3M |
| Idexx Laboratories, Inc. | 1.2% | Unchanged | 58,595 | $29.4M |
| Dexcom, Inc. | 1.2% | Unchanged | 228,747 | $29.4M |
| Bristol-myers Squibb Company | 1.1% | Trimmed 31% | 458,498 | $29.3M |
| Intuitive Surgical, Inc. | 1.1% | Trimmed 25% | 83,980 | $28.7M |
| Alnylam Pharmaceuticals, Inc. | 1.1% | Unchanged | 143,214 | $27.2M |
| The Cigna Group | 1.1% | Trimmed 47% | 96,339 | $27M |
| Mckesson Corp. | 1.0% | Trimmed 6.8% | 61,955 | $26.5M |
| Argenx Se | 1.0% | Trimmed 26% | 65,553 | $25.5M |
| Hca Healthcare, Inc. | 1.0% | Trimmed 7.1% | 82,403 | $25M |
| Stryker Corp. | 1.0% | Added 13% | 81,128 | $24.8M |
| Iqvia Holdings Inc. | 1.0% | Added 73% | 109,129 | $24.5M |
| Zoetis Inc. | 0.9% | Unchanged | 136,914 | $23.6M |
| Charles River Laboratories International, Inc. | 0.9% | Trimmed 5.8% | 111,183 | $23.4M |
| Seagen Inc. | 0.8% | Trimmed 50% | 112,331 | $21.6M |
| Sarepta Therapeutics, Inc. | 0.8% | Trimmed 37% | 179,437 | $20.5M |
| NN Novo Nordisk A/s | 0.8% | Added 10% | 122,777 | $19.9M |
| Oculis Holding Ag | 0.7% | Unchanged | 1,690,741 | $18.8M |
| Molina Healthcare, Inc. | 0.7% | Unchanged | 61,856 | $18.6M |
| Jazz Pharmaceuticals PLC | 0.7% | Unchanged | 147,779 | $18.3M |
| Biomarin Pharmaceutical Inc. | 0.7% | Trimmed 30% | 210,789 | $18.3M |
| Edwards Lifesciences Corp. | 0.7% | Added 11% | 189,597 | $17.9M |
| Humana Inc. | 0.6% | Unchanged | 36,794 | $16.5M |
| Apellis Pharmaceuticals, Inc. | 0.6% | Added 28% | 173,248 | $15.8M |
| Baxter International, Inc. | 0.6% | Added 382% | 324,370 | $14.8M |
| Exelixis, Inc. | 0.5% | Unchanged | 726,639 | $13.9M |
| Novartis Ag | 0.5% | Unchanged | 136,225 | $13.7M |
| Karuna Therapeutics, Inc. | 0.5% | Added 9.6% | 58,577 | $12.7M |
| Insulet Corp. | 0.5% | New | 43,847 | $12.6M |
| Guardant Health, Inc. | 0.5% | Trimmed 27% | 346,084 | $12.4M |
| Ascendis Pharma A/s | 0.5% | Added 12% | 138,791 | $12.4M |
| SS SPDR S&P Biotech ETF | 0.5% | Unchanged | 147,677 | $12.3M |
| PR Physicians Realty Trust | 0.5% | Unchanged | 873,655 | $12.2M |
| Tenet Healthcare Corp. | 0.5% | New | 149,070 | $12.1M |
| Biontech Se | 0.4% | Unchanged | 103,858 | $11.2M |
| Neurocrine Biosciences, Inc. | 0.4% | Unchanged | 112,908 | $10.6M |
| Zimmer Biomet Holdings, Inc. | 0.4% | Unchanged | 67,356 | $9.81M |
| Rallybio Corporation | 0.4% | Unchanged | 1,727,067 | $9.78M |
| Vaxcyte, Inc. | 0.4% | Added 3785% | 194,232 | $9.7M |
| Alkermes PLC | 0.4% | Unchanged | 309,613 | $9.69M |
| Denali Therapeutics, Inc. | 0.4% | Unchanged | 324,829 | $9.59M |
Showing top 60 of 166 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2023 · filed August 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Eli Lilly And Company | Trimmed | −75,565 | −$35.4M | 3.9% |
| The Cigna Group | Trimmed | −86,292 | −$24.2M | 1.1% |
| Seagen Inc. | Trimmed | −112,332 | −$21.6M | 0.8% |
| Merck & Co., Inc. | Added | +176,032 | +$20.3M | 3.3% |
| Amgen Inc. | Added | +60,600 | +$13.5M | 5.4% |
| Regeneron Pharmaceuticals, Inc. | Added | +18,365 | +$13.2M | 4.5% |
| Bristol-myers Squibb Company | Trimmed | −205,298 | −$13.1M | 1.1% |
| Unitedhealth Group Inc. | Trimmed | −27,212 | −$13.1M | 3.9% |
| Insulet Corp. | New | +43,847 | +$12.6M | 0.5% |
| Sarepta Therapeutics, Inc. | Trimmed | −106,216 | −$12.2M | 0.8% |
Showing the 10 largest of 88 changes.
quarter ended March 31, 2023 · filed May 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| HT Horizon Therapeutics PLC | Exited | −415,053 | −$47.2M | — |
| Elevance Health, Inc. | Added | +99,426 | +$45.7M | 2.0% |
| Stryker Corp. | Trimmed | −92,550 | −$26.4M | 0.8% |
| Zimmer Biomet Holdings, Inc. | Trimmed | −191,512 | −$24.7M | 0.3% |
| Seagen Inc. | Added | +112,449 | +$22.8M | 1.7% |
| Lantheus Holdings, Inc. | Trimmed | −263,377 | −$21.7M | 0.2% |
| Sarepta Therapeutics, Inc. | Added | +144,694 | +$19.9M | 1.5% |
| Humana Inc. | Trimmed | −40,919 | −$19.9M | 0.7% |
| Regeneron Pharmaceuticals, Inc. | Added | +22,191 | +$18.2M | 4.5% |
| Unitedhealth Group Inc. | Trimmed | −36,373 | −$17.2M | 4.2% |
Showing the 10 largest of 87 changes.
quarter ended December 31, 2022 · filed February 10, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| HT Horizon Therapeutics PLC | Trimmed | −319,300 | −$36.3M | 1.8% |
| Johnson & Johnson | Trimmed | −144,100 | −$25.5M | 4.3% |
| Humana Inc. | Trimmed | −35,291 | −$18.1M | 1.5% |
| Eli Lilly And Company | Added | +48,339 | +$17.7M | 4.0% |
| Astrazeneca PLC | Trimmed | −250,938 | −$17M | 2.6% |
| Pfizer Inc. | Added | +325,067 | +$16.7M | 2.8% |
| Molina Healthcare, Inc. | Trimmed | −45,920 | −$15.2M | 0.9% |
| Biogen Inc. | Added | +49,991 | +$13.8M | 2.0% |
| Bristol-myers Squibb Company | Trimmed | −191,947 | −$13.8M | 1.9% |
| Mckesson Corp. | Added | +32,798 | +$12.3M | 0.9% |
Showing the 10 largest of 82 changes.
quarter ended September 30, 2022 · filed November 01, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Johnson & Johnson | Added | +267,127 | +$43.6M | 5.2% |
| Mckesson Corp. | Trimmed | −127,065 | −$43.2M | 0.5% |
| Humana Inc. | Added | +49,210 | +$23.9M | 2.2% |
| Regeneron Pharmaceuticals, Inc. | Trimmed | −33,802 | −$23.3M | 3.1% |
| Unitedhealth Group Inc. | Trimmed | −45,464 | −$23M | 5.7% |
| SH Syneos Health, Inc. | Exited | −302,945 | −$21.7M | — |
| Eli Lilly And Company | Added | +64,146 | +$20.7M | 3.2% |
| Seagen Inc. | Trimmed | −141,796 | −$19.4M | 0.3% |
| Illumina, Inc. | Added | +98,896 | +$18.9M | 2.3% |
| Becton, Dickinson And Company | Exited | −73,930 | −$18.2M | — |
Showing the 10 largest of 103 changes.
quarter ended June 30, 2022 · filed July 29, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Seagen Inc. | Trimmed | −135,378 | −$24M | 1.4% |
| Mckesson Corp. | Trimmed | −45,300 | −$14.8M | 2.1% |
| Vertex Pharmaceuticals Inc. | Added | +52,347 | +$14.8M | 4.0% |
| Eli Lilly And Company | Trimmed | −35,400 | −$11.5M | 2.2% |
| Medtronic PLC | Trimmed | −108,968 | −$9.78M | 1.2% |
| Intuitive Surgical, Inc. | Added | +48,570 | +$9.75M | 0.8% |
| Astrazeneca PLC | Added | +134,066 | +$8.86M | 2.9% |
| SS SPDR S&P Biotech ETF | Added | +113,505 | +$8.43M | 0.6% |
| Boston Scientific Corp. | Added | +225,817 | +$8.42M | 1.2% |
| Lantheus Holdings, Inc. | New | +127,092 | +$8.39M | 0.3% |
Showing the 10 largest of 71 changes.
quarter ended March 31, 2022 · filed May 13, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Moderna, Inc. | Trimmed | −218,100 | −$37.6M | 2.0% |
| Thermo Fisher Scientific Inc. | Trimmed | −54,721 | −$32.3M | 2.0% |
| Merck & Co., Inc. | Trimmed | −212,500 | −$17.4M | 1.7% |
| AP Arena Pharmaceuticals, Inc. | Exited | −175,976 | −$16.4M | — |
| Danaher Corp. | Trimmed | −52,215 | −$15.3M | 1.5% |
| Astrazeneca PLC | Added | +203,190 | +$13.5M | 2.3% |
| Mettler-toledo International Inc. | Exited | −6,650 | −$11.3M | — |
| Stryker Corp. | Added | +42,096 | +$11.3M | 2.1% |
| Idexx Laboratories, Inc. | Trimmed | −18,446 | −$10.1M | 1.2% |
| Seagen Inc. | Trimmed | −68,966 | −$9.93M | 1.7% |
Showing the 10 largest of 75 changes.
quarter ended December 31, 2021 · filed February 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Pfizer Inc. | Added | +721,524 | +$42.6M | 2.2% |
| Seagen Inc. | Added | +192,193 | +$29.7M | 2.0% |
| Biogen Inc. | Trimmed | −98,214 | −$23.6M | 1.0% |
| Moderna, Inc. | Added | +87,168 | +$22.1M | 4.5% |
| Exact Sciences Corp. | Exited | −225,282 | −$21.5M | — |
| Catalent, Inc. | Exited | −143,913 | −$19.2M | — |
| C Cigna Corp. | Trimmed | −78,317 | −$18M | 1.1% |
| Danaher Corp. | Added | +53,677 | +$17.7M | 2.1% |
| Dentsply Sirona Inc. | Trimmed | −310,121 | −$17.3M | 0.1% |
| SH Syneos Health, Inc. | Added | +159,454 | +$16.4M | 1.3% |
Showing the 10 largest of 100 changes.
quarter ended September 30, 2021 · filed November 12, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rallybio Corp. | New | +2,308,672 | +$37.6M | 1.2% |
| A Anthem, Inc. | Trimmed | −93,090 | −$34.7M | 0.2% |
| Resmed Inc. | Trimmed | −123,618 | −$32.6M | 0.1% |
| Guardant Health, Inc. | Added | +229,257 | +$28.7M | 1.6% |
| Idexx Laboratories, Inc. | Added | +44,849 | +$27.9M | 1.6% |
| Amgen Inc. | Added | +111,513 | +$23.7M | 3.9% |
| Vertex Pharmaceuticals Inc. | Trimmed | −122,242 | −$22.2M | 1.6% |
| Astrazeneca PLC | Added | +364,629 | +$21.9M | 1.6% |
| Dexcom, Inc. | Trimmed | −39,775 | −$21.8M | 0.8% |
| Sarepta Therapeutics, Inc. | Added | +233,290 | +$21.6M | 1.3% |
Showing the 10 largest of 133 changes.
Loading...
